# State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/state-budget-institution-of-health-st-petersburg-clinical-research-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 10.5 |
| Citations | 5,465 |
| City | Saint Petersburg |
| Country | RU |
| Description | State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care is a research organisation in Saint Petersburg, RU. OpenAlex records 465 works and 5,465 citations for it. 205 researchers list it as their most recent affiliation. |
| Homepage | http://oncocentre.ru/ |
| OpenAlex ID | https://openalex.org/I4210148464 |
| Researchers | 205 |
| ROR ID | https://ror.org/05ss6ff26 |
| Type | healthcare |
| Works | 465 |

## University papers

Showing 12 of 18.

- [Tumor acidity: From hallmark of cancer to target of treatment](https://scholariq.org/papers/tumor-acidity-from-hallmark-of-cancer-to-target-of-treatment/)
- [Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer](https://scholariq.org/papers/final-results-of-right-choice-ribociclib-plus-endocrine-therapy-versus/)
- [Effect of silver oxide nanoparticles on tumor growth in vivo](https://scholariq.org/papers/effect-of-silver-oxide-nanoparticles-on-tumor-growth-in-vivo/)
- [\[Results of a prospective randomized investigation \[Russia (St.Petersburg)/WHO\] to evaluate the significance of self-examination for the early detection of breast cancer\].](https://scholariq.org/papers/results-of-a-prospective-randomized-investigation-russia-st-petersburg-who-to/)
- [\[Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)\].](https://scholariq.org/papers/interim-results-of-a-prospective-randomized-study-of-self-examination-for-early/)
- [Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study](https://scholariq.org/papers/trifluridine-tipiracil-plus-bevacizumab-in-patients-with-untreated-metastatic/)
- [Breast self-examination for the early detection of breast cancer: a USSR/WHO controlled trial in Leningrad.](https://scholariq.org/papers/breast-self-examination-for-the-early-detection-of-breast-cancer-a-ussr-who/)
- [Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer](https://scholariq.org/papers/efficacy-of-immune-checkpoint-blockade-in-mutyh-associated-hereditary-colorectal/)
- [Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion](https://scholariq.org/papers/resistance-mechanisms-to-drug-therapy-in-breast-cancer-and-other-solid-tumors-an/)
- [Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer](https://scholariq.org/papers/evidence-for-predictive-role-of-brca1-and-btubiii-in-gastric-cancer/)
- [The emergence of hypervirulent blaNDM-1-positive Klebsiella pneumoniae sequence type 395 in an oncology hospital](https://scholariq.org/papers/the-emergence-of-hypervirulent-blandm-1-positive-klebsiella-pneumoniae-sequence/)
- [Clinical activity and safety of simlukafusp alfa, an engineered interleukin-2 variant targeted to fibroblast activation protein-α, combined with atezolizumab in patients with recurrent or metastatic cervical cancer.](https://scholariq.org/papers/clinical-activity-and-safety-of-simlukafusp-alfa-an-engineered-interleukin-2/)

## University researchers

- [В. Моисеенко](https://scholariq.org/researchers/a5112141652/)
- [Nikita Volkov](https://scholariq.org/researchers/nikita-volkov/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.